findmyKOL
Clinical trialNCT05607420RecruitingPhase 1/PHASE2Interventional

Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma

SponsorCellectis S.A.Enrollment80B-cell Non-Hodgkin Lymphoma (B-NHL)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Hospices Civils de Lyon (hcl) - Centre Hospitalier Lyon-Sud

    Pierre-Bénite, Auvergne Rhone Alpe, France

    Emmanuel Bachy
    Recruiting
  • Centre Hospitalier Universitaire de Montpellier (chu Montpellier) - Hopital Saint-Eloi

    Montpellier, Occitanie, France

    Guillaume Cartron
    Recruiting
  • Assistance Publique-Hopitaux de Paris (ap-Hp) - Hopital Saint-Louis - Centre Integre En Cancerologie

    Paris, Île-de-France Region, France

    Catherine Thieblemont
    Recruiting
  • Centre Hospitalier Universitaire de Nantes (chu de Nantes)-Hotel-Dieu

    Nantes, France

    Thomas Gastinne
    Recruiting
Spain
  • Universidad de Navarra - Clinica Universidad de Navarra (cun) - Pamplona

    Pamplona, Navarre, Spain

    Ana Alfonso
    Recruiting
  • Hospital Universitario Virgen del Rocio (huvr) - Instituto de Biomedicina de Sevilla (ibis)

    Seville, Spain

    Jose Antonio Perez Simon
    Recruiting
United States
  • the University of Chicago Medical Center (ucmc)

    Chicago, Illinois, United States

    Peter Riedell
    Recruiting
  • Harvard Medical School - Massachusetts General Hospital

    Boston, Massachusetts, United States

    Jeremy Abramson
    Recruiting
  • Rutgers Cancer Institute of New Jersey (cinj) - New Brunswick

    New Brunswick, New Jersey, United States

    Matthew Matasar
    Recruiting
  • Sarah Cannon - St. David South Austin Medical Center

    Austin, Texas, United States

    Aravind Ramakrishnan
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Nov 2022
Primary completion
31 Aug 2027
Completion
31 Aug 2027
Last update posted
24 Aug 2025
Registered enrollment
80
Registry id
NCT05607420
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.